Liquid Chromatography-Mass Spectrometry (LC-MS) Analysis in Therapeutic Drug Monitoring
What’s in the eBook
The efficacy and clinical utility of Therapeutic Drug Monitoring (TDM) rely on the specific, sensitive, and reproducible measurement of analytes. Liquid Chromatography coupled with Mass Spectrometry (LC-MS) has emerged as an attractive alternative to traditional immunoassays.
There are several commercial CE-IVD-certified tests for TDM on the market. However, most automated methods are currently run as Laboratory-Developed Tests (LDTs).
We believe that LC-MS has the potential to become the gold standard for TDM. Therefore, we have collaborated with Chromsystems to develop the MassSTAR, a CE-IVD-certified automated solution that will soon (in 2023) also be compliant with IVDR.
Read the full eBook to learn more.